Fulgent Genetics Inc. (NASDAQ: FLGT) stock closed at 52.72 per share at the end of the most recent trading day (a -11.93% change compared to the prior day closing price) with a volume of 701.31K shares and market capitalization of 1.52B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 139 people. Fulgent Genetics Inc. CEO is Ming Hsieh.

The one-year performance of Fulgent Genetics Inc. stock is -51.97%, while year-to-date (YTD) performance is -47.59%. FLGT stock has a five-year performance of 834.75%. Its 52-week range is between 47.34 and 112, which gives FLGT stock a 52-week price range ratio of 4.27%

Fulgent Genetics Inc. currently has a PE ratio of 3.90, a price-to-book (PB) ratio of 1.36, a price-to-sale (PS) ratio of 2.17, a price to cashflow ratio of 3.70, a PEG ratio of 2.32, a ROA of 38.24%, a ROC of 42.90% and a ROE of 44.66%. The company’s profit margin is 47.63%, its EBITDA margin is 65.50%, and its revenue ttm is $799.81 Million , which makes it $26.37 revenue per share.

Of the last four earnings reports from Fulgent Genetics Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.59 for the next earnings report. Fulgent Genetics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fulgent Genetics Inc. is Strong Buy (1), with a target price of $70, which is +39.72% compared to the current price. The earnings rating for Fulgent Genetics Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fulgent Genetics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fulgent Genetics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 17.83, ATR14 : 2.93, CCI20 : -183.27, Chaikin Money Flow : -0.05, MACD : 0.76, Money Flow Index : 52.56, ROC : -12.57, RSI : 30.80, STOCH (14,3) : 0.88, STOCH RSI : 0.00, UO : 40.82, Williams %R : -99.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fulgent Genetics Inc. in the last 12-months were: Han Lin Gao (Sold 950 shares of value $76 919 ), Jian Xie (Sold 32 508 shares of value $2 152 264 ), John C. Bolger (Option Excercise at a value of $13 519), John C. Bolger (Sold 1 750 shares of value $111 799 ), Paul Kim (Sold 17 401 shares of value $1 568 454 )